Research graph
References from A recombinant pseudorabies virus co-expressing G2b and G2c S1 broadens neutralizing antibody responses against PEDV variants and enhances pre-existing vaccine-induced antibody responses. Local targets link to admitted publications; unresolved targets remain external evidence.
Febrifugine dihydrochloride restricts porcine epidemic diarrhea virus replication by modulating the IGF1R-driven PI3K/AKT-apoptosis axis
10.1128/jvi.00117-26 · 2026 · External reference
Establishment of stable Vero cell lines expressing TMPRSS2 and MSPL: a useful tool for propagating porcine epidemic diarrhea virus in the absence of exogenous trypsin
10.1080/21505594.2020.1770491 · 2020 · External reference
An apparently new syndrome of porcine epidemic diarrhoea
10.1136/vr.100.12.243 · 1977 · External reference
Recombinant AAV vaccine expressing PEDV S1 enhances immunity with superior neonatal protection
10.1038/s41541-025-01248-0 · 2025 · External reference
Completion of the porcine epidemic diarrhoea coronavirus (PEDV) genome sequence
10.1023/a:1011831902219 · 2001 · External reference
Intestinal mucosal immune responses induced by oral administration of chitosan nanoparticles encapsulating the PEDV S1 protein
10.1186/s13567-025-01695-6 · 2025 · External reference
Neutralizing antibodies against porcine epidemic diarrhea virus block virus attachment and internalization
10.1186/s12985-018-1042-3 · 2018 · External reference
Molecular characterization and phylogenetic analysis of porcine epidemic diarrhea virus strains circulating in China from 2020 to 2021
10.1186/s12917-022-03481-4 · 2022 · External reference
Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies
10.1371/journal.ppat.1002859 · 2012 · External reference
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
10.1016/j.cell.2021.06.020 · 2021 · External reference
Structure and immune recognition of the porcine epidemic diarrhea virus spike protein
10.1016/j.str.2020.12.003 · 2021 · External reference
Emergence of a highly virulent porcine epidemic diarrhea virus (PEDV) G2c subtype in China: isolation, genetic and pathogenic characterization, and cross-neutralizing antibody response
10.1155/tbed/3811264 · 2026 · External reference
Isolation and characterization of porcine epidemic diarrhea virus G2c strains circulating in China from 2021 to 2024
10.3390/vetsci12050444 · 2025 · External reference
Isolation and oral immunogenicity assessment of porcine epidemic diarrhea virus NH-TA2020 strain: one of the predominant strains circulating in China from 2017 to 2021
10.1016/j.virs.2022.08.002 · 2022 · External reference
Characterization and pathogenicity of Vero cell-attenuated porcine epidemic diarrhea virus CT strain
10.1186/s12985-019-1232-7 · 2019 · External reference
Assessment of the safety and efficacy of an attenuated live vaccine based on highly virulent genotype 2b porcine epidemic diarrhea virus in nursing piglets
10.1016/j.vetmic.2019.03.009 · 2019 · External reference
Cell attachment domains of the porcine epidemic diarrhea virus spike protein are key targets of neutralizing antibodies
10.1128/jvi.00273-17 · 2017 · External reference
Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine
10.1128/mmbr.69.3.462-500.2005 · 2005 · External reference
Contribution of single genes within the unique short region of Aujeszky’s disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity
10.1099/0022-1317-73-2-243 · 1992 · External reference
Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2
10.1016/j.vetmic.2005.06.001 · 2005 · External reference
Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6
10.1186/s12985-020-1292-8 · 2020 · External reference
The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice
10.1186/s12985-025-02641-w · 2025 · External reference
Pathogenicity and immunogenicity of a quadruple gene-deleted pseudorabies virus variant as a vaccine candidate
10.1016/j.vetmic.2023.109931 · 2024 · External reference
Pteropine orthoreoviruses use cell surface heparan sulphate as an attachment receptor
10.1080/22221751.2023.2208683 · 2023 · External reference
Intranasal vaccination with gB adjuvanted by poly(I:C) induces complete protection against pseudorabies virus in swine
10.1016/j.vetmic.2026.110935 · 2026 · External reference
Alphaherpesvirus infection of mice primes PNS neurons to an inflammatory state regulated by TLR2 and type I IFN signaling
10.1371/journal.ppat.1008087 · 2019 · External reference
The construction and immunogenicity analyses of a recombinant pseudorabies virus with Senecavirus A VP3 protein co-expression
10.1016/j.vetmic.2024.110011 · 2024 · External reference
Immunogenic response of recombinant pseudorabies virus carrying B646L and B602L genes of African swine fever virus in mice
10.1016/j.vetmic.2023.109815 · 2023 · External reference
Pseudorabies virus as a live virus vector for expression of foreign genes
10.1016/0378-1119(87)90130-2 · 1987 · External reference
A triple gene-deleted pseudorabies virus-vectored subunit PCV2b and CSFV vaccine protect pigs against a virulent CSFV challenge
10.3390/v15112143 · 2023 · External reference
Recombinant PRV expressing GP3 and GP5 of PRRSV provides effective protection against coinfection with PRV and PRRSV
10.1155/tbed/4612568 · 2025 · External reference
Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus
10.1099/vir.0.059253-0 · 2014 · External reference
Construction and evaluation of quadruple-gene-deleted pseudorabies virus platforms for ASFV antigen delivery
10.1155/tbed/3628600 · 2025 · External reference
Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV
10.1016/j.antiviral.2019.104652 · 2020 · External reference
Dual induction of tissue-resident T and B cell immunity for broad influenza protection with a nanofiber-VLP vaccine
2026 · External reference
Propagation of the virus of porcine epidemic diarrhea in cell culture
10.1128/jcm.26.11.2235-2239.1988 · 1988 · External reference
Receptor-bound porcine epidemic diarrhea virus spike protein cleaved by trypsin induces membrane fusion
10.1007/s00705-011-1044-6 · 2011 · External reference
Role of proteases in the release of porcine epidemic diarrhea virus from infected cells
10.1128/jvi.00464-11 · 2011 · External reference
Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture
10.1128/jvi.00297-14 · 2014 · External reference
Immunogenicity and protective efficacy of recombinant S1 domain of the porcine epidemic diarrhea virus spike protein
10.1007/s00705-014-2163-7 · 2014 · External reference
Identification of four insertion sites for foreign genes in a pseudorabies virus vector
10.1186/s12917-021-02887-w · 2021 · External reference
A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs
10.1016/j.vaccine.2007.12.050 · 2008 · External reference
A recombinant pseudorabies virus surface - displaying the classical swine fever E2 protein induces specific antibodies rapidly
10.1016/j.vetmic.2024.110240 · 2024 · External reference
A simple selection system for construction of recombinant gD-negative pseudorabies virus as a vaccine vector
10.1016/s0264-410x(01)00426-1 · 2002 · External reference
Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice
10.3389/fmicb.2022.976220 · 2022 · External reference
Enhancing the breadth of protection in mice with a multivalent influenza vaccine
10.1038/s42003-025-09451-4 · 2026 · External reference
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials
10.1038/s41467-024-55087-z · 2024 · External reference
The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing epitopes
10.1016/j.virol.2017.06.013 · 2017 · External reference
Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions
10.1016/j.virusres.2016.06.002 · 2016 · External reference
Immunogenicity of a recombinant parapoxvirus expressing the spike protein of Porcine epidemic diarrhea virus
10.1099/jgv.0.000586 · 2016 · External reference
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine
10.1038/s41467-023-43339-3 · 2023 · External reference
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost
10.1038/s41541-019-0114-8 · 2019 · External reference
